$KGKG
Kona Gold Beverage Inc Stock $kgkg

$kgkg Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010169 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.275M	$1.144M	$4.443M
YoY Change	28.11%	68.29%	79.25%
Cost Of Revenue	$986.9K	$842.5K	$3.451M
YoY Change	16.12%	20.41%	61.02%
Gross Profit	$288.0K	$301.5K	$991.9K
YoY Change	98.3%	-1615.89%	195.75%
Gross Profit Margin	22.59%	26.36%	22.32%
Selling, General & Admin	$1.274M	$1.078M	$4.148M
YoY Change	35.62%	-22.88%	22.59%
% of Gross Profit	442.29%	357.7%	418.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$24.03K	$26.38K	$100.7K
YoY Change	-8.21%	1.66%	71.56%
% of Gross Profit	8.34%	8.75%	10.15%
Operating Expenses	$1.274M	$1.102M	$4.148M
YoY Change	35.62%	-22.09%	22.59%
Operating Profit	-$985.9K	-$800.9K	-$3.156M
YoY Change	24.16%	-44.18%	-28.03%
Interest Expense	$293.6K	-$199.5K	$1.041M
YoY Change	-31.86%	-76.56%	5.93%
% of Operating Profit
Other Income/Expense, Net	$131.00	-$5.790K	-$338.00
YoY Change	-95.94%	-100.3%	-98.5%
Pretax Income	-$1.593M	-$1.171M	-$7.313M
YoY Change	-55.33%	-55.37%	4.17%
Income Tax
% Of Pretax Income
Net Earnings	-$1.593M	-$1.171M	-$7.313M
YoY Change	-55.28%	-54.91%	4.17%
Net Earnings / Revenue	-124.92%	-102.35%	-164.6%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	2.139B shares	1.841B shares	1.598B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$76.61K	$39.79K	$39.79K
YoY Change	-74.19%	-94.35%	-94.35%
Cash & Equivalents	$76.61K	$39.79K
Short-Term Investments
Other Short-Term Assets		$45.26K	$45.26K
YoY Change		49.02%	-85.36%
Inventory	$643.0K	$859.2K	$859.2K
Prepaid Expenses
Receivables	$13.14K	$79.53K	$79.53K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$732.7K	$1.024M	$1.024M
YoY Change	-53.04%	-36.16%	-36.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$325.7K	$348.1K	$1.111M
YoY Change	-5.72%	0.01%	-15.55%
Goodwill		$1.337M
YoY Change		0.0%
Intangibles	$63.76K	$66.20K
YoY Change	-13.27%	-12.84%
Long-Term Investments
YoY Change
Other Assets	$13.35K	$15.13K	$15.13K
YoY Change	-11.76%	0.0%	0.0%
Total Long-Term Assets	$1.111M	$1.192M	$1.192M
YoY Change	-17.83%	-15.24%	-15.24%
TOTAL ASSETS
Total Short-Term Assets	$732.7K	$1.024M	$1.024M
Total Long-Term Assets	$1.111M	$1.192M	$1.192M
Total Assets	$1.844M	$2.216M	$2.216M
YoY Change	-36.7%	-26.39%	-26.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.587M	$1.379M	$1.379M
YoY Change	48.03%	154.88%	154.88%
Accrued Expenses	$363.5K	$346.8K	$346.8K
YoY Change	-27.44%	-36.19%	-36.19%
Deferred Revenue
YoY Change
Short-Term Debt	$629.4K	$411.1K	$411.1K
YoY Change	-3.55%	-51.64%	-51.64%
Long-Term Debt Due	$2.517M	$2.498M	$2.498M
YoY Change	629.73%	17782.25%	17782.25%
Total Short-Term Liabilities	$5.751M	$5.295M	$5.295M
YoY Change	27.74%	28.22%	28.22%
LONG-TERM LIABILITIES
Long-Term Debt	$58.00K	$57.06K	$57.06K
YoY Change	-95.78%	-96.32%	-96.32%
Other Long-Term Liabilities	$579.2K		$629.2K
YoY Change	-5.88%		-56.73%
Total Long-Term Liabilities	$637.2K	$0.00	$686.3K
YoY Change	3.55%	-100.0%	-77.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.751M	$5.295M	$5.295M
Total Long-Term Liabilities	$637.2K	$0.00	$686.3K
Total Liabilities	$6.388M	$5.981M	$5.981M
YoY Change	-12.18%	-16.17%	-16.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.21M	-$23.61M
YoY Change	26.91%	44.86%
Common Stock	$21.39K	$20.00K
YoY Change	44.28%	99.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.545M	-$3.765M	-$3.765M
YoY Change
Total Liabilities & Shareholders Equity	$1.844M	$2.216M	$2.216M
YoY Change	-36.7%	-26.39%	-26.39%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.593M	-$1.171M	-$7.313M
YoY Change	-55.28%	-54.91%	4.17%
Depreciation, Depletion And Amortization	$24.03K	$26.38K	$100.7K
YoY Change	-8.21%	1.66%	71.56%
Cash From Operating Activities	-$215.5K	-$350.9K	-$2.500M
YoY Change	-67.81%	-69.32%	-8.46%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$1.500K	$44.42K
YoY Change	-100.0%	-103.07%	-77.2%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities		-$1.500K	-$44.42K
YoY Change		-100.12%	-77.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$252.4K	121.4K	$1.880M
YoY Change	-11.01%	67.49%	-46.59%
NET CHANGE
Cash From Operating Activities	-$215.5K	-350.9K	-$2.500M
Cash From Investing Activities		-1.500K	-$44.42K
Cash From Financing Activities	$252.4K	121.4K	$1.880M
Net Change In Cash	$36.82K	-231.0K	-$664.0K
YoY Change	-109.05%	-246.85%	-212.42%
FREE CASH FLOW
Cash From Operating Activities	-$215.5K	-$350.9K	-$2.500M
Capital Expenditures	$0.00	$1.500K	$44.42K
Free Cash Flow	-$215.5K	-$352.4K	-$2.544M
YoY Change	-68.79%	-67.81%	-13.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001802546
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent		usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	KGKG	Gains Losses On Extinguishment Of Paycheck Protection Program GainsLossesOnExtinguishmentOfPaycheckProtectionProgram		usd
CY2021	KGKG	Stock Issued During Period Value Preferred Stock Conversion To Common Stock StockIssuedDuringPeriodValuePreferredStockConversionToCommonStock		usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	KGKG	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan		usd
CY2022	KGKG	Increase Decrease In Deposit IncreaseDecreaseInDeposit		usd
CY2022	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers		usd
CY2022	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty		usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022	KGKG	Proceeds From Ppp Notes Payable ProceedsFromPppNotesPayable		usd
CY2022	KGKG	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition		usd
CY2022	KGKG	Noncash Recording Of Right Of Use Asset And Lease Liability NoncashRecordingOfRightOfUseAssetAndLeaseLiability		usd
CY2021	KGKG	Fair Value Of Common Stock Issues With Note Payable Received As Debt Discount FairValueOfCommonStockIssuesWithNotePayableReceivedAsDebtDiscount		usd
CY2021	KGKG	Fair Value Of Warrants Issued Upon Issuance Of Convertible Notes FairValueOfWarrantsIssuedUponIssuanceOfConvertibleNotes		usd
CY2022Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	KGKG	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2021	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2021	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56230
CY2022	dei	Entity Registrant Name EntityRegistrantName	KONA GOLD BEVERAGE, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-1915692
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	746 North Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Melbourne
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32934
CY2022	dei	City Area Code CityAreaCode	(844)
CY2022	dei	Local Phone Number LocalPhoneNumber	714-2224
CY2022	dei	Security12b Title Security12bTitle	Common Stock
CY2022	dei	Trading Symbol TradingSymbol	KGKG
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	13997332	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2139440557	shares
CY2022	dei	Auditor Firm AuditorFirmId	572
CY2022	dei	Auditor Name AuditorName	Weinberg & Company, P.A.
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	us-gaap	Cash Cash	39788	usd
CY2021Q4	us-gaap	Cash Cash	703825	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	145579	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11926	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	79529	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15993	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	859179	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	574811	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	278707	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45262	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	30373	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1023758	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1603709	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348064	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348037	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	762464	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	966955	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	66201	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	75955	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	15125	usd
CY2022Q4	us-gaap	Assets Assets	2215612	usd
CY2021Q4	us-gaap	Assets Assets	3009781	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1379227	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	541123	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	137083	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	329583	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	712499	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	7974	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1785651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	659550	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	60000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	209685	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	213837	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	411060	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	849933	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5294755	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4129450	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1525651	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57055	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	25338	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	615317	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3156464	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	629197	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	838883	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5981007	usd
CY2021Q4	us-gaap	Liabilities Liabilities	7134639	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5702000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5702000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	10	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2000276378	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2000276378	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1004709546	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1004709546	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	20003	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10047	usd
CY2022Q4	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	169999860	shares
CY2021Q4	KGKG	Common Stock Issuable Shares CommonStockIssuableShares	169999860	shares
CY2022Q4	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2021Q4	KGKG	Common Stock Issuable CommonStockIssuable	1386497	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18441303	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10778761	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23613208	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16300173	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2215612	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3009781	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4443036	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2478736	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3451163	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2143359	usd
CY2022	us-gaap	Gross Profit GrossProfit	991873	usd
CY2021	us-gaap	Gross Profit GrossProfit	335377	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4148337	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3383879	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1337287	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-4385789	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9323	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1337287	usd
CY2022	KGKG	Financing Costs FinancingCosts	286000	usd
CY2021	KGKG	Financing Costs FinancingCosts	1335000	usd
CY2022	us-gaap	Interest Expense InterestExpense	1040651	usd
CY2021	us-gaap	Interest Expense InterestExpense	982378	usd
CY2022	KGKG	Financing Cost Expense FinancingCostExpense	286019	usd
CY2021	KGKG	Financing Cost Expense FinancingCostExpense	1335000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1523000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	549714	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1306563	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1056732	usd
CY2021	KGKG	Gains Losses On Extinguishment Of Paycheck Protection Program GainsLossesOnExtinguishmentOfPaycheckProtectionProgram	212648	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-338	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-22600	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7313035	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7020137	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1598164109	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	875322747	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2857654	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	213800	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	243000	usd
CY2021	KGKG	Adjustments To Additional Paid In Capital Warrants Related To Convertible Note AdjustmentsToAdditionalPaidInCapitalWarrantsRelatedToConvertibleNote	1583000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3713133	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7020137	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4124858	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	7201998	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	135000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	31500	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	304000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7313035	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7313035	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-7020137	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	90967	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	49390	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	133653	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	-70000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	150000	usd
CY2022	KGKG	Rightofuse Asset Amortization RightofuseAssetAmortization	204491	usd
CY2021	KGKG	Rightofuse Asset Amortization RightofuseAssetAmortization	291697	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	847950	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	774496	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	9754	usd
CY2022	KGKG	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	1306563	usd
CY2021	KGKG	Losses On Extinguishment Of Debt LossesOnExtinguishmentOfDebt	1056732	usd
CY2022	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities	-1523000	usd
CY2021	KGKG	Gain On Change In Fair Value Of Derivative Liabilities GainOnChangeInFairValueOfDerivativeLiabilities	549714	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	31500	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	213800	usd
CY2021	KGKG	Gain On Forgiveness Of Ppp Loan GainOnForgivenessOfPPPLoan	212648	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	197189	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16768	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	214368	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-185339	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-278707	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	278707	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	14889	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	9925	usd
CY2021	KGKG	Increase Decrease In Deposit IncreaseDecreaseInDeposit	8625	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	996059	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	66186	usd
CY2021	us-gaap	Increase Decrease In Payables To Customers IncreaseDecreaseInPayablesToCustomers	-10508	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-192500	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	72083	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-206181	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-198433	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2499518	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2730596	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44418	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	194792	usd
CY2021	KGKG	Payments For Proceeds From In Intellectual Property PaymentsForProceedsFromInIntellectualProperty	3590	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-44418	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-198382	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	260000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	6000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	31500	usd
CY2022	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	15767	usd
CY2021	KGKG	Proceeds From Payment Of Acquisition Obligation ProceedsFromPaymentOfAcquisitionObligation	463932	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7657	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7499	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	852059	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	180411	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	399921	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	977675	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4305000	usd
CY2021	KGKG	Proceeds From Ppp Notes Payable ProceedsFromPppNotesPayable	117487	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1879899	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3519635	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-664037	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	590657	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	703825	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	113168	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39788	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	703825	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	6101	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	22600	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	13149	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	120740	usd
CY2021	KGKG	Common Stock Issued For Acquisition CommonStockIssuedForAcquisition	243000	usd
CY2021	KGKG	Noncash Recording Of Right Of Use Asset And Lease Liability NoncashRecordingOfRightOfUseAssetAndLeaseLiability	345659	usd
CY2022	KGKG	Fair Value Of Derivative Liability Created Upon Issuance Of Convertible Debenture And Warrants FairValueOfDerivativeLiabilityCreatedUponIssuanceOfConvertibleDebentureAndWarrants	680000	usd
CY2021	KGKG	Fair Value Of Derivative Liability Created Upon Issuance Of Convertible Debenture And Warrants FairValueOfDerivativeLiabilityCreatedUponIssuanceOfConvertibleDebentureAndWarrants	3982000	usd
CY2022	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	7201998	usd
CY2021	KGKG	Common Shares Issued On Conversion Of Debentures And Accrued Interest CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest	3713133	usd
CY2022	KGKG	Issuance Of Loan Payable For Vehicle Purchase IssuanceOfLoanPayableForVehiclePurchase	46576	usd
CY2021	KGKG	Issuance Of Loan Payable For Vehicle Purchase IssuanceOfLoanPayableForVehiclePurchase	34763	usd
CY2022	KGKG	Fair Value Of Common Stock Issues With Note Payable Received As Debt Discount FairValueOfCommonStockIssuesWithNotePayableReceivedAsDebtDiscount	135000	usd
CY2022	KGKG	Fair Value Of Warrants Issued Upon Issuance Of Convertible Notes FairValueOfWarrantsIssuedUponIssuanceOfConvertibleNotes	304000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-7313035	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2499518	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3765395	usd
CY2022Q4	us-gaap	Cash Cash	39788	usd
CY2022	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	760000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4443036	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2478736	usd
CY2022	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.79	pure
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	296000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1337000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	1633000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1337287	usd
CY2022Q4	KGKG	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	57055	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zBBmip0lmueh" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_zzctBnS49yU6">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	145579	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	11926	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1337287	usd
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2022	KGKG	Sales Percentage SalesPercentage	0.03	pure
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4443036	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2478736	usd
CY2022	KGKG	Revenue From Contract With Customer Excluding Assessed Tax Percentage RevenueFromContractWithCustomerExcludingAssessedTaxPercentage	0.79	pure
CY2022	us-gaap	Advertising Expense AdvertisingExpense	192786	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	164052	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	33312	usd
CY2022Q4	KGKG	Notes Payable Current Portion NotesPayableCurrentPortion	712499	usd
CY2021Q4	KGKG	Notes Payable Current Portion NotesPayableCurrentPortion	7974	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1188330823	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1614615110	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1188330823	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1614615110	shares
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_z1KvyNXba8H6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zIUXTVte8hda">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zp6aj6ThYsyl" title="Cash FDIC insured amount">250,000</span>. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross sales.</i> During the year ended December 31, 2022, the Company reported no customers that accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zfMRXu5FZMs1" title="Concentration risk, percentage">10</span>% of gross sales. During the year ended December 31, 2021, the Company reported no customers that accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zQsBkeqYiDi8" title="Concentration risk, percentage">10</span>% of gross sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of December 31, 2022, the Company had accounts receivable from two customers that comprised <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zstFM0SjxF48" title="Concentration risk percentage">27</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zOdOm7WJKEFg" title="Concentration risk percentage">20</span>% of its gross accounts receivable. As of December 31, 2021, the Company had accounts receivable from two customers that comprised <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zDlnFPVP8iS1" title="Concentration risk percentage">36</span>% and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zqDx32zrnDo" title="Concentration risk percentage">24</span>% of its gross accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Co-Packers. </i>The raw materials used in the production of the Company’s products are obtained by the Company’s co-packers and consist primarily of materials such as the flavors, caffeine, sugars or sucralose, taurine, vitamins, CBD, and hemp seed protein contained in its beverages, the bottles in which its beverages are packaged, and the labeling on the outside of its beverages. These principal raw materials are subject to price and availability fluctuations. The Company currently relies on a few key co-packers, which in turn rely on a few key suppliers. The Company continually endeavors to have back-up co-packers, which co-packers would in turn depend on their third-party suppliers to supply certain of the flavors and concentrates that are used in the Company’s beverages. The Company is also dependent on these co-packers to negotiate arrangements with their existing suppliers that would enable the Company to obtain access to certain of such concentrates or flavor formulas under certain extraordinary circumstances. Additionally, in a limited number of cases, the Company’s co-packers may have contractual restrictions with their suppliers or the Company’s co-packers may need to obtain regulatory approvals and licenses that may limit the co-packers’ ability to enter into agreements with alternative suppliers. Contractual restrictions in the agreements the Company has with certain distributors may also limit the Company’s ability to enter into agreements with alternative distributors. The Company believes that a satisfactory supply of co-packers will continue to be available at competitive prices, although there can be no assurance in this regard. With respect to Gold Leaf’s operations, the Company continually endeavors to contract with additional beverage vendors to ensure the Company has adequate inventory. The Company believes that a satisfactory supply of vendors will continue to be available at competitive prices, although there can be no assurance in this regard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the year ended December 31, 2022, the Company’s largest one vendor accounted for approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zMxdqBY1lnG">34</span>% of all purchases, respectively. During the year ended December 31, 2021, the Company’s largest three vendors accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zR1EnlHVOge8">13</span>%, <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zMsyXlm1nS38">11</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorThreeMember_zTeDuneZCN32">10</span>% of all purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of December 31, 2022, two vendors accounted for more than <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--TwoVendorMember_zUIhmLvZ3bph" title="Concentration risk, percentage">10</span>% the total accounts payable. The Company’s largest two vendors accounted for <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_z8iCFM3Tyvpc">31</span>%, and <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorTwoMember_zZfmO0iiwsxj">18</span>% of the total accounts payable, respectively. As of December 31, 2021, four vendors accounted for more than 10% the total accounts payable. The Company’s largest four vendors accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zrKTQgSPLeM2">20</span>%, <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_z7mNTbBYAdEc">14</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zA6CLoOB2au5">12</span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_z30NzSAJJ9C3">11</span>% of the total accounts payable, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	1633000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	198605	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	70592	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	660574	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	504219	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	859179	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	574811	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	80000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	150000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	543152	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	452158	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	195088	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	104121	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348064	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	348037	usd
CY2022	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	340000	usd
CY2022	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	1050000	usd
CY2022	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	243000	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2021Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	85340	usd
CY2022Q4	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2021Q4	KGKG	Finite Lived Gross Website Development Trademarks FiniteLivedGrossWebsiteDevelopmentTrademarks	12200	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31339	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21585	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	66201	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	75955	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	9754	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	9323	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	9754	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	9754	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	9754	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	9754	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9754	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	17431	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	66201	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1785651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1531651	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1785651	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	1525651	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	988035	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	33312	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	218481	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	769554	usd
CY2021Q4	KGKG	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	25338	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	153018	usd
CY2022	KGKG	Derivative Liabilities Issued DerivativeLiabilitiesIssued	680000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2020	KGKG	Fair Value Of Derivative Liability Created Upon Issuance Of Convertible Debenture And Warrants FairValueOfDerivativeLiabilityCreatedUponIssuanceOfConvertibleDebentureAndWarrants	361152	usd
CY2021	KGKG	Fair Value Of Derivative Liability Created Upon Issuance Of Convertible Debenture And Warrants FairValueOfDerivativeLiabilityCreatedUponIssuanceOfConvertibleDebentureAndWarrants	3982000	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	550152	usd
CY2021	KGKG	Loss On Extinguishment Of Derivative Liabilities LossOnExtinguishmentOfDerivativeLiabilities	1672000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2022	KGKG	Fair Value Of Derivative Liability Created Upon Issuance Of Convertible Debenture And Warrants FairValueOfDerivativeLiabilityCreatedUponIssuanceOfConvertibleDebentureAndWarrants	680000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	3500000	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2121000	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	4324000	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1523000	usd
CY2022	KGKG	Loss On Extinguishment Of Derivative Liabilities LossOnExtinguishmentOfDerivativeLiabilities	4324000	usd
CY2022	us-gaap	Lease Cost LeaseCost	204491	usd
CY2021	us-gaap	Lease Cost LeaseCost	291697	usd
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	912993	usd
CY2021Q4	KGKG	Operating Leases OperatingLeases	345659	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	291697	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	966955	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	204491	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	762464	usd
CY2020Q4	KGKG	Lease Liabilities LeaseLiabilities	912993	usd
CY2020Q4	KGKG	Finance Lease Liabilities FinanceLeaseLiabilities	32980	usd
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	880013	usd
CY2021Q4	KGKG	Operating Leases OperatingLeases	345659	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7499	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	198433	usd
CY2021Q4	KGKG	Lease Liabilities LeaseLiabilities	1052720	usd
CY2021Q4	KGKG	Finance Lease Liabilities FinanceLeaseLiabilities	25481	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1027239	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	7657	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	206181	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	209685	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	629197	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y29D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1000	pure
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0209	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	282347	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	262715	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	261083	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	198217	usd
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1004362	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	165480	usd
CY2022Q4	KGKG	Present Value Of Net Minimum Lease Payments PresentValueOfNetMinimumLeasePayments	838882	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	209685	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	629197	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	988000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	988000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2000276378	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2000276378	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1004709546	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1004709546	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	20000000	shares
CY2020Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.05
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	150000000	shares
CY2021	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.03
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	170000000	shares
CY2021Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.03
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	108333333	shares
CY2022	KGKG	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0065
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	278333333	shares
CY2022Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.0223
CY2022Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	278333333	shares
CY2022Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Weighted Average Exercisable Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsWeightedAverageExercisablePrice	0.0223
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	278333333	shares
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P2Y6M10D
CY2022	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Outstanding Non Options Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOutstandingNonOptionsWeightedAverageExercisePrice	0.03
CY2022Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	278333333	shares
CY2022Q4	KGKG	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	0.03
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.0032
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	14288000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.060	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.060	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2700	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2700	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3864000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2756000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3864000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2756000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10500000000	shares

Files In Submission

Name	View Source	Status
0001493152-23-010169-index-headers.html	Edgar Link	pending
0001493152-23-010169-index.html	Edgar Link	pending
0001493152-23-010169.txt	Edgar Link	pending
0001493152-23-010169-xbrl.zip	Edgar Link	pending
ex10-52.htm	Edgar Link	pending
ex10-53.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-14.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
kgkg-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
kgkg-20221231_def.xml	Edgar Link	unprocessable
kgkg-20221231_lab.xml	Edgar Link	unprocessable
kgkg-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
kgkg-20221231_cal.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KGKG
Kona Gold Beverage Inc Stock $kgkg

2023 Q1 Form 10-K Financial Statement

#000149315223010169 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG Kona Gold Beverage Inc Stock $kgkg

2023 Q1 Form 10-K Financial Statement

#000149315223010169 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KGKG
Kona Gold Beverage Inc Stock $kgkg